KRISTI GORE-STEWART: Open Payments
NPI 1669758389 · ATHENS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 55 payments from 13 companies in 2025. Trend: 2023 $113 · 2024 $537 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $534 |
| EVOKE PHARMA, INC. | 5 | $161 |
| Madrigal Pharmaceuticals | 8 | $146 |
| Janssen Biotech, Inc. | 2 | $130 |
| Phathom Pharmaceuticals, Inc. | 5 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Novo Nordisk Inc | 2 | $39 |
| Braintree Laboratories, Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
Products named: RINVOQ, GIMOTI, REZDIFFRA, TREMFYA, LINZESS, MAVYRET, VOQUEZNA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
